REGN Balance Sheet
Regeneron Pharmaceuticals Inc - Assets, Liabilities & Stockholders' Equity
Total Assets
$40.56B
Total Liabilities
$9.30B
Shareholders' Equity
$31.26B
Cash Position
$3.12B
Assets
As of: FY
Current Assets
Cash & Equivalents
$3.12B
Total Current Assets
$18.02B
Non-Current Assets
Total Assets
$40.56B
Liabilities & Equity
Current Liabilities
Total Current Liabilities
$4.37B
Non-Current Liabilities
Total Liabilities
$9.30B
Stockholders' Equity
Retained Earnings
$35.80B
Total Equity
$31.26B
Total Liabilities & Equity
$40.56B
Should equal Total Assets
Key Balance Sheet Ratios
Current Ratio
4.13
Current Assets / Current Liabilities
Working Capital
$13.65B
Current Assets - Current Liabilities
Balance Sheet Health
Liquidity: Strong
Current ratio of 4.13 indicates the company has ample short-term assets to cover short-term liabilities.
Cash Position: 7.7% of Assets
$3.12B in cash provides adequate financial flexibility.
View Complete Financial Analysis
Explore detailed financials, income statements, cash flows, and more
Open Full FinancialsFrequently Asked Questions
What are REGN's total assets?
REGN has total assets of $40.56B, up from $37.76B in the previous period.
How much debt does REGN have?
Debt information for REGN can be found in the balance sheet.
What is REGN's cash position?
REGN has $3.12B in cash and cash equivalents, representing 7.7% of total assets.
What is REGN's stockholders' equity?
REGN's stockholders' equity is $31.26B. This represents the book value of the company and shareholder ownership stake.
What is REGN's current ratio?
REGN has a current ratio of 4.13. This means the company has $4.13 in current assets for every $1 in current liabilities. A ratio above 1.0 indicates good short-term financial health.
How healthy is REGN's balance sheet?
REGN's balance sheet shows $40.56B in total assets, $9.30B in liabilities, and $31.26B in equity. The current ratio of 4.13 suggests strong liquidity.